(+/-)-trans-4-(Benzo[d][1,3]dioxol-5-yl)-3-(4-fluorophenyl)-1-(piperidin-4-yl)azetidin-2-one

ID: ALA3787437

PubChem CID: 127034181

Max Phase: Preclinical

Molecular Formula: C21H21FN2O3

Molecular Weight: 368.41

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C1[C@H](c2ccc(F)cc2)[C@@H](c2ccc3c(c2)OCO3)N1C1CCNCC1

Standard InChI:  InChI=1S/C21H21FN2O3/c22-15-4-1-13(2-5-15)19-20(14-3-6-17-18(11-14)27-12-26-17)24(21(19)25)16-7-9-23-10-8-16/h1-6,11,16,19-20,23H,7-10,12H2/t19-,20-/m1/s1

Standard InChI Key:  QPVQOPSMQFJCMD-WOJBJXKFSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   -3.9638    2.9172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4118    2.5255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0201    1.0775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6168    1.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2004    4.2093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7374    4.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2375    5.8944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2124    7.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6871    6.7603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1870    5.3460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7510   -0.2332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2474   -1.6332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2167   -2.7779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6928   -2.5108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1995   -1.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2301    0.0457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4524    3.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8125    8.1659    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  1  1  0
  5  6  2  0
  6 24  1  0
 23  7  1  0
  7  8  2  0
  8  5  1  0
  4  5  1  1
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  1  9  1  6
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  3 15  1  0
  2 21  2  0
 12 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3787437

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 368.41

Molecular Weight (Monoisotopic): 368.1536

AlogP: 2.97

#Rotatable Bonds: 3

Polar Surface Area: 50.80

Molecular Species: BASE

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 10.03

CX LogP: 2.23

CX LogD: -0.31

Aromatic Rings: 2

Heavy Atoms: 27

QED Weighted: 0.85

Np Likeness Score: -0.23

References

1. Brindisi M, Maramai S, Gemma S, Brogi S, Grillo A, Di Cesare Mannelli L, Gabellieri E, Lamponi S, Saponara S, Gorelli B, Tedesco D, Bonfiglio T, Landry C, Jung KM, Armirotti A, Luongo L, Ligresti A, Piscitelli F, Bertucci C, Dehouck MP, Campiani G, Maione S, Ghelardini C, Pittaluga A, Piomelli D, Di Marzo V, Butini S..  (2016)  Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.,  59  (6): [PMID:26888301] [10.1021/acs.jmedchem.5b01812]

Source

Source(1):

• Scientific Literature